Biocon Stock Forecast

Stock Price Forecast

According to 20 analysts polled by S&P Global, Biocon stock has a consensus rating of "Buy" and an average price target of ₹416.55. The average 1-year stock price forecast is 0.41% lower than the current stock price, while the lowest is ₹290.00 (-30.66%) and the highest is ₹506.00 (+20.98%).

Price Target: ₹416.55 (-0.41%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹290.00	₹416.55	₹417.50	₹506.00
Change	-30.66%	-0.41%	-0.18%	+20.98%

* Price targets were last updated on Feb 17, 2026.

Analyst Ratings

The average analyst rating for Biocon stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	10	9	9	8	8	9
Buy	3	3	3	3	3	2
Hold	2	2	2	3	3	3
Sell	4	4	4	5	5	5
Strong Sell	0	1	1	1	1	1
Total	19	19	19	20	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Axis Direct No rating	Axis Direct	Buy Maintains ₹435.00	Buy	Maintains	₹435.00	+4.00%	Feb 17, 2026

Financial Forecast

Revenue This Year

200.07B

from 169.27B

18.20%

from 169.27B

Revenue Next Year

228.83B

from 200.07B

14.37%

from 200.07B

EPS This Year

7.96

from 5.25

51.71%

from 5.25

EPS Next Year

11.68

from 7.96

46.74%

from 7.96

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	81.84B	111.74B	147.56B	152.62B	169.27B	200.07B
Revenue Growth	14.57%	36.54%	32.05%	3.43%	10.91%	18.20%
Gross Profit	50.11B	69.62B	91.74B	92.44B	112.36B	132.25B
Gross Margin	61.23%	62.30%	62.17%	60.57%	66.38%	66.10%
Operating Income	11.58B	15.64B	17.83B	15.43B	14.99B	24.17B
Net Income	6.48B	4.63B	10.23B	10.13B	3.86B	13.22B
EPS	-	-	-	-	5.25	7.96
EPS Growth	-	-	-	-	-33.17%	51.71%
Forward PE	35.74	21.39	34.10	56.28	61.80	52.55
Dividend / Share	0.50	1.50	0.50	0.50	0.50	0.65
Dividend Growth	-	200.00%	-66.67%	-	-	30.98%
Free Cash Flow	-12.38B	1.40B	27.61B	-28.16B	-466.13M	22.25B
No. Analysts	-	-	-	-	-	17

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	210.6B
Avg	200.1B
Low	191.4B

Revenue Growth

Revenue Growth	2027	2028	2029
High	24.4%
Avg	18.2%
Low	13.1%

EPS Forecast

EPS	2027	2028	2029
High	11.30
Avg	7.96
Low	3.30

EPS Growth

EPS Growth	2027	2028	2029
High	115.4%
Avg	51.7%
Low	-37.1%